After the successful launch of the Dutch Life Science Outlook 2012, Dutch media published the report’s key messages in newspapers, and in newsitems on Dutch television.
Key messages
Most attention was paid to the survey-based forecasts that start-up and smaller companies in the biotechnology will get under high pressure if they don’t get access to private and public investments. Contrary to the focus chosen by Dutch newspapers, the key conclusions from the Outlook 2012 according to The Decision Group are:
- Growth and outperformance: The Dutch lsh cluster shows growth in size and products and ouperforms the Dutch economy on growth in number of companies and employment.
- Positive Expectations: Entrepreneurs have positive expectations of the future despite disappearence of large companies.
- Partnering: Facilitating (international) partnerships remains very important or future growth of the companies in the Dutch lsh cluster.
Het Financieel Dagblad, the newspaper with an economic and financial focus, spent two articles on the Dutch Life Science Outlook 2012:
- Geldstroom ‘life sciences’ dreigt op te drogen – FD of Thursday 19 January 2012, page 14
- Subsidie schraagt groei life sciences – FD of Monday 23 January 2012
Furthermore, a special news item about the changes in the Life Sciences Sector based on the Outlook, was broadcast by RTL Z, the financial news channel.
Life Sciences and The Decision Group
The Decision Group has extensive expertise on Life Sciences. Our client list includes many companies in big pharma as well as in medical devices and biotech. This expertise is underlined by the yearly published Dutch Life Sciences Outlook.
More information about The Decision Group’s work on Life Sciences can be found on our special website.
The Dutch Life Sciences Outlook 2012 can be downloaded from our dedicated website www.lifesciencesoutlook.com.
Official press release of Outlook 2012 by Life Science & Health: Stijging aantal bedrijven en werkgelegenheid biotech sector
On Wednesday January 18th, Prof. dr. F. van Eenennaam, partner of The Decision Group, presented the Dutch Life Sciences Outlook for a group of 60 key stakeholders in Life Sciences. The Outlook yearly monitors Dutch Life Sciences & Health Cluster success and measures performance and progress of the sector. This yearly systematic Outlook is created in close collaboration between The Decision Group and Life Sciences Health.
Clusters & Competitiveness
Prior to presenting the Outlook, Prof dr. F. van Eenennaam gave a Masterclass on Cluster Development, where theory and practicalities of clusters were discussed, as well as implications for Dutch policy makers. The Decision Group has extensive expertise on Clusters & Competitiveness. See also our Clusters & Competitiveness website
The Dutch Life Sciences Outlook 2012 can be downloaded from our dedicated website www.lifesciencesoutlook.com.
In the December edition of VM (Verenigingsmanagement Magazine; Click to download the full article), Prof. dr. Fred van Eenennaam, ir. Roald van Leeuwen and ir. Niels van Gorp set an outline on how to stay ‘ahead of the curve’ in association management. The underlying question is: how to deal with increased uncertainty while keeping up with the rapid speed of changing environment. The suggestions and practical tips are illustrated by best practices of the shape strategy in diverse industries. In the article, Dirk Hogervorst of FloraHolland shares insights on moments of truth for the cooperative flower auction and on how they manage to stay ahead of the curve as a cluster.
The Decision Group and Association Management
Since 1998, The Decision Group has extensive expertise in projects on Clusters and Competitiveness. The Decision Group has helped monitoring clusters success, developed strategic plans and scenario’s and is active in association management. Our work in clusters has academic grounding through Prof. Dr. Fred van Eenennaam’s connects to Harvard’s Microeconomics of Competitiveness course and international network.
More information of our approach and examples about Association Management and Clusters can be found in on this page.
After four years of working for The Decision Group and The Decision Institute, dr. Paul van der Nat says goodbye. Paul has meant a lot for the company over the past years.
St Antonius Hospital Nieuwegein
At the start of this new year, Paul switches jobs and will start in January in the St Antonius Hospital in Nieuwegein as Senior Policy Advisor to the hospital board. The Decision Group wishes Paul all the best with his new career.
With great pride and enthusiasm we have presented with Hans Schikan (CEO Prosensa) the making of the Prosensa case. The presentation was held at The 30- minute session of NGI’s Life Sciences Momentum 2011.
Background on the Prosensa case:
Currently a consortium consisting of NGI, LUMC, LSH, Prosensa, PGGM, Leiden University and The Decision Group are developing the Prosensa case. The objective of the case is to demonstrate a success story of the Dutch biotech cluster which can be used for teaching at various universities and for promotional activities within the Netherlands or abroad.
Outcome Measures in Cardiology
Friday the 23rd of September St. Antonius hospital and AstraZeneca organized a successful conference on innovation and outcomes in cardiology. The speakers focused on the status and developments on healthcare quality measurement and reporting from the perspective of health insurers (Ms. D. Monissen, De Friesland), hospitals (Ir. D. M. Schraven, St. Antonius hospital), and cardiologists (prof. S.K. James, MD, PhD). Prof. dr. Fred van Eenennaam started off the conference with a presentation on the methodology and implementation of outcome measures in hospital care. Focus of his presentation are the newest insight and developments of The Decision Group from research and cooperation in their international network with The George Washington University, St. Gallen Universitat, and Harvard Business School. The conference showed a high-level of interaction between cardiologists, hospital executives, patient representatives and government policy makers.
Please feel free to contact us personally to discuss this topic and the possible opportunities for your organization.
ir. Maarten Koomans
dr. Paul van der Nat
prof. dr. Fred van Eenennaam
The Decision Group on Outcome Measures
On September 23rd, Antonius hospital and AstraZeneca organize a symposium on innovation, quality and outcomes in cardiology. Partner of The Decision Group, Prof. dr. Fred van Eenennaam presents the latest insights on Outcome Measures.
Nieuwegein conferentie:Innovatie,kwaliteit en outcomes in cardiologie. 23 september 2011 from algemeen on Vimeo.
Program in short
As first speaker, Prof. Fred van Eenennaam will start of the conference with a presentation on outcome measures. The program will end with a promising discussion between Fred and Diana Monissen (CEO De Friesland), Dirk Schraven (board Antonius hospital), and Prof. James Upsalla. Ab Klink, the former Minister of Health Welfare and Sports will open the discussion with his challenging vision for the Dutch healthcare system.
Invitation.
On the embedded video above, you will find a complete overview of the program, including an invitation by Dr. J.M. ten Berg. You can apply for registration online at: https://www.benecke.nl/.
For more information on Outcome Measures and what The Decision Group can do for your organization, do not hesitate to send an e-mail to Healthcare Partner ir. Maarten Koomans, or prof. dr. Fred van Eenennaam, or call us at +31 (0)346 574 942
From our international work on outcome measures, we would like to bring your attention to this (click to read the full article) interesting study by USA today of Medicare data:
The focus on relevant outcome measures is a key part of improving health care delivery (see also Quality-based selection of hospitals for Transcatheter Heart Valve Interventions and the symposium we organized about the results of this study ). Process measures, structure measures, different types of cost measures, quality measures, medically relevant patient outcome measures, patient reported outcome measures, health economic measures and patient perception and satisfaction measures have all been intertwined. This strongly obscures effective decision making in healthcare. In our work and with the collaborations with Prof Porter (Outcome Measures project ) and others the opion is that medically relevant patient outcomes should be the yard stick for decision making.
Whether patient perception and satisfaction measures (client measures) can be used as valid indicators to get insight in the quality of health outcomes has been debated for some time now. The study of the Medicare data suggests at least to take extreme care in assuming a relationship.
Please feel free to contact us personally to discuss this topic and the possible opportunities for your organization.
ir. Maarten Koomans
dr. Paul van der Nat
prof. dr. Fred van Eenennaam
Plans for the Dutch topsectors LSH sector presented to Minister Verhagen
The 9 topsectors the Dutch government has assigned presented their individual sectorplans to the minister of Economic Affairs on friday June 17th. Life Sciences and Health is one of the 9 topsectors that presented their ambition and action agenda for the next 10-15 years. To measure progress on the action agenda, the methodology developed by The Decision Group together with Life Science & Health innovationprogramme is mentioned.
Measuring methodology
The methodology that was developed by The Decision Group to monitor the performance and progress in the Dutch Life Sciences & Health (LSH) sector has been acknowledged by the topsector. Our data on the core of innovative companies in the Dutch cluster was used to indicate the size and output of the cluster. And moreover, the way we measure the size, in- and output of the Dutch LSH cluster is seen as a proven methodology to monitor progress of the cluster’s ambition and agenda and provides a baseline for measuring progress in the next years.
To request a copy of the Dutch Life Sciences Outlook 2011, click here.
To read more on the Dutch Life Sciences Outlook, see here.
Click the picture to enlarge.
